Pretreatment quality assurance of volumetric modulated arc therapy on patient CT scan using indirect 3D dosimetry system

Shanmugam Thirumalai Swamy, Chandrasekaran Anuradha, Murugesan Kathirvel, Gandhi Arun, Shanmuga Subramanian


Purpose: Aim of this study is to clinically implement the COMPASS 3D dosimetry system for pretreatment quality assurance of volumetric modulated arc therapy (VMAT-RapidArc) treatment plans.

Methods: For this study, 10 head and neck (H&N) and 10 pelvis VMAT plans dose response from Linac was measured using COMPASS system along with MatriXXEvolution and 3D dose was reconstructed in the patient computed tomography (CT) scan. Dose volume histograms and 3D gamma were used to evaluate the difference between the measured and calculated values. In order to validate the COMPASS system, dose response for open fields were acquired for both homogeneous and inhomogeneous phantoms.

Results: The average dose difference between Eclipse treatment planning system (TPS) calculated and COMPASS measured (homogenous medium) in normalization region, inner region, penumbra region and buildup region was less than ±2%. In inhomogeneous phantom, there was a maximum difference of -3.17% in lung, whereas the difference other densities was within ±2%. The systematic increase in the average 3D gamma between the TPS calculated and COMPASS measured for VMAT plans with known dose errors and multi-leaf collimator (MLC) offset errors shows that COMPASS system was sensitive enough to find clinical significant errors. The 3D dose parameters (D95, D1, and average dose) of all H&N and pelvis patients were well within the clinically acceptable tolerance level of ±5%. The average 3D gammas for planning target volumes (PTV) and organ at risks (OAR) of the patients were less than 0.6.

Conclusion: The results from this study show that COMPASS along with MatriXXEvolution can be effectively used for pretreatment verification of VMAT plans in the patient anatomy.


COMPASS; VMAT; 3D Gamma; Pretreatment QA

Full Text:



Vanetti E, Clivio A, Nicolini G, et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009; 92:111-7.

Rana S, Pokharel S, Zheng Y, et al. Treatment planning study comparing proton therapy, RapidArc and intensity modulated radiation therapy for a synchronous bilateral lung cancer case. Int J Cancer Ther Oncol 2014; 2:020216.

Subramanian S, Srinivas C, Ramalingam K, et al. Volumetric modulated arc-based hypofractionated stereotactic radiotherapy for the treatment of selected intracranial arteriovenous malformations: dosimetric report and early clinical experience. Int J Radiat Oncol Biol Phys 2012; 82:1278-84.

Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys 2003; 30:2089-115.

Dong L, Antolak J, Salehpour M, et al. Patient-specific point dose measurement for IMRT monitor unit verification. Int J Radiat Oncol Biol Phys 2003; 56:867-77.

Masi L, Casamassima F, Doro R, Francescon P. Quality assurance of volumetric modulated arc therapy: Evaluation and comparison of different dosimetric systems. Med Phys 2011; 38: 612-22.

Herzen J, Todorovic M, Cremers F, et al. Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine. Phys Med Biol 2007; 52:1197-208.

Fenoglietto P, Laliberte B, Ailleres N, et al. Eight years of IMRT quality assurance with ionization chambers and film dosimetry: experience of the Montpellier Comprehensive Cancer Center. Radiat Oncol 2011; 6:85.

Paule MC, Indrin JC, Shigeru Y, Benedick AF. Dosimetric comparison of extended dose range film with ionization measurements in water and lung equivalent heterogeneous media exposed to megavoltage photons. J Appl Clinc Med Phys 2003; 4:25-39.

Howell RM, Smith IP, Jarrio CS. Establishing action levels for EPID-based QA for IMRT. J Appl Clin Med Phys 2008; 9: 16-25.

Nicolini G, Vanetti E, Clivio A, et al. The GLAaS algorithm for portal dosimetry and quality assurance of RapidArc, an intensity modulated rotational therapy. Radiat Oncol 2008; 3:24.

Nelms BE, Zhen H, Tomé WA. Per-beam, planar IMRT QA passing rates do not predict clinically relevant patient dose errors. Med Phys 2011; 38:1037-44.

Boggula R, Jahnke L, Wertz H, et al. Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans. Int J Radiat Oncol Biol Phys 2011; 81:1168-75.

Boggula R, Lorenz F, Mueller L, et al. Experimental validation of a commercial 3D dose verification system for intensity-modulated arc therapies. Phys Med Biol 2010; 55:5619-33.

Korevaar EW, Wauben DJ, van der Hulst PC, et al. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT. Radiother Oncol 2011; 100:446-52.

Godart J, Korevaar EW, Visser R, et al. Reconstruction of high-resolution 3D dose from matrix measurements: error detection capability of the COMPASS correction kernel method. Phys Med Biol 2011; 56:5029-43.

Visser R, Wauben DJ, de Groot M, et al. Efficient and reliable 3D dose quality assurance for IMRT by combining independent dose calculations with measurements. Med Phys 2013; 40:021710.

Venkataraman S, Malkoske KE, Jensen M, et al. The influence of a novel transmission detector on 6 MV x-ray beam characteristics. Phys Med Biol 2009; 54:3173-83.

Fraass B, Doppke K, Hunt M, et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med Phys 1998; 25:1773-829.

Hasenbalg F, Neuenschwander H, Mini R, Born EJ. Collapsed cone convolution and analytical anisotropic algorithm dose calculations compared to VMC++ Monte Carlo simulations in clinical cases. Phys Med Biol 2007; 52:3679-91.

Fredh A, Scherman JB, Fog LS, Rosenschöld PM. Patient QA systems for rotational radiation therapy: a comparative experimental study with intentional errors. Med Phys 2013; 40:031716.

Thwaites D. Accuracy required and achievable in radiotherapy dosimetry: have modern technology and techniques changed our views? J Phys 2013; 444: 012006.

Park JY, Kim S, Park HJ, et al. Optimal set of grid size and angular increment for practical dose calculation using the dynamic conformal arc technique: a systematic evaluation of the dosimetric effects in lung stereotactic body radiation therapy. Radiat Oncol 2014; 9:5.

Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010; 37:4078-101.

Kunnanchath J, Majumdar SKD, Tharmarnadar G, et al. Validation of compass QA system and the independent verification of dose calculation algorithm for IMRT patient specific plans. Transworld Medical Journal 2014; 2:170-5.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013